Literature DB >> 9691230

Formation and retention of cotinine during placental transfer of nicotine in human placental cotyledon.

B V Sastry1, M B Chance, M E Hemontolor, T A Goddijn-Wessel.   

Abstract

Maternal smoking during pregnancy causes reduction of fetal breathing movements, an effect attributed to nicotine in fetal blood. Nicotine is metabolized to cotinine which has a long plasma half-life and exhibits slow clearance across membrane barriers. It is also known to activate placental phospholipase-A2-like enzymes, resulting in formation of prostaglandins. Therefore, we studied transport of nicotine in isolated perfused cotyledon of normal human term placenta. The placental cotyledon was perfused with aerated (21% O2, 5% CO2) Krebs-Ringer bicarbonate buffer (pH 7.4, 37 degrees C) containing 2% albumin on both maternal (230 ml, 15 ml/min, 35 mm Hg) and fetal (93 ml, 1.75 ml/min, 70 mm Hg) sides in a closed recirculating system. Nicotine (2 mg) was added to the maternal perfusate; perfusate samples (1 ml) were collected from both sides at regular intervals and analyzed for nicotine and cotinine by high-pressure liquid chromatography. This study gave the following results: (1) In about 60-80 min, 18.6% of the nicotine added to the maternal perfusate was transferred to the fetal perfusate, and the maternal/fetal concentration ratio reached 1.0. These results show rapid placental transfer of nicotine, consistent with its high lipid solubility. (2) Less than 1% is metabolized to cotinine in placenta. The ratio of cotinine concentrations in maternal and fetal perfusates reached 1.0 in about 40 min. These studies were also verified using 14C-nicotine. (3) Maximal reduction in fetal breathing movements occurs at about 30 min, and recovery occurs at 90 min after tobacco smoking by the mother. These observations agree with the rate of placental transfer of nicotine. (4) When nicotine was added on the fetal side, part of it was metabolized to cotinine. However, the maximal concentration of cotinine was twice higher on fetal than on maternal side. These observations suggest that accumulation of cotinine on fetal side may activate prostaglandin formation and trigger spontaneous abortions in pregnant smokers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9691230     DOI: 10.1159/000028231

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  12 in total

1.  Brain metabolic effects of acute nicotine.

Authors:  J W Pettegrew; K Panchalingam; R J McClure; J Levine
Journal:  Neurochem Res       Date:  2001-02       Impact factor: 3.996

2.  The effects of prenatal secondhand smoke exposure on preterm birth and neonatal outcomes.

Authors:  Kristin B Ashford; Ellen Hahn; Lynne Hall; Mary Kay Rayens; Melody Noland; James E Ferguson
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2010 Sep-Oct

3.  Does Maternal Exposure to Secondhand Tobacco Smoke During Pregnancy Increase the Risk for Preterm or Small-for-Gestational Age Birth?

Authors:  Adrienne T Hoyt; Mark A Canfield; Paul A Romitti; Lorenzo D Botto; Marlene T Anderka; Sergey V Krikov; Marcia L Feldkamp
Journal:  Matern Child Health J       Date:  2018-10

Review 4.  Risks and benefits of nicotine to aid smoking cessation in pregnancy.

Authors:  D A Dempsey; N L Benowitz
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

5.  Meconium nicotine and metabolites by liquid chromatography-tandem mass spectrometry: differentiation of passive and nonexposure and correlation with neonatal outcome measures.

Authors:  Teresa R Gray; Raquel Magri; Diaa M Shakleya; Marilyn A Huestis
Journal:  Clin Chem       Date:  2008-10-09       Impact factor: 8.327

6.  Quantification of nicotine, cotinine, trans-3'-hydroxycotinine, nornicotine and norcotinine in human meconium by liquid chromatography/tandem mass spectrometry.

Authors:  Teresa R Gray; Diaa M Shakleya; Marilyn A Huestis
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-01-16       Impact factor: 3.205

7.  Measuring prenatal secondhand smoke exposure in mother-baby couplets.

Authors:  Kristin B Ashford; Ellen Hahn; Lynne Hall; Mary K Rayens; Melody Noland; Rebecca Collins
Journal:  Nicotine Tob Res       Date:  2009-12-27       Impact factor: 4.244

Review 8.  Guidelines on nicotine dose selection for in vivo research.

Authors:  Shannon G Matta; David J Balfour; Neal L Benowitz; R Thomas Boyd; Jerry J Buccafusco; Anthony R Caggiula; Caroline R Craig; Allan C Collins; M Imad Damaj; Eric C Donny; Phillip S Gardiner; Sharon R Grady; Ulrike Heberlein; Sherry S Leonard; Edward D Levin; Ronald J Lukas; Athina Markou; Michael J Marks; Sarah E McCallum; Neeraja Parameswaran; Kenneth A Perkins; Marina R Picciotto; Maryka Quik; Jed E Rose; Adrian Rothenfluh; William R Schafer; Ian P Stolerman; Rachel F Tyndale; Jeanne M Wehner; Jeffrey M Zirger
Journal:  Psychopharmacology (Berl)       Date:  2006-08-09       Impact factor: 4.530

Review 9.  Life-long programming implications of exposure to tobacco smoking and nicotine before and soon after birth: evidence for altered lung development.

Authors:  Gert S Maritz; Richard Harding
Journal:  Int J Environ Res Public Health       Date:  2011-03-16       Impact factor: 3.390

10.  The Yin and Yang of Nicotine: Harmful during Development, Beneficial in Adult Patient Populations.

Authors:  Danielle S Counotte; August B Smit; Sabine Spijker
Journal:  Front Pharmacol       Date:  2012-10-08       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.